Patents Assigned to AstraZeneca AB (PUBL)
  • Compounds useful for the treatment of conditions associated with weight gain
    Patent number: 8093248
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: January 10, 2012
    Assignee: AstraZeneca AB (PUBL)
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom, Viet-Anh Anne Horgan (Nee Nguyen), Jaqueline Ouzman, Iain Simpson
  • NEW COMPOUNDS I
    Publication number: 20110046135
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Application
    Filed: November 1, 2010
    Publication date: February 24, 2011
    Applicant: ASTRAZENECA AB (PUBL)
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom
  • Compounds I
    Patent number: 7851471
    Abstract: The present application relates to new compounds of formula (I), to pharmaceutical compositions comprising the compounds, to processes for their preparation, and to the use of the compounds as leptin receptor modulator mimetics in the preparation of medicaments against conditions associated with weight gain, type 2 diabetes and dyslipidemias.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: December 14, 2010
    Assignee: AstraZeneca AB (PUBL)
    Inventors: Joseph W. Boyd, Giles A. Brown, Michael Higginbottom